We knew that treatment for sepsis is crucial and urgent for the health and survival of millions of people throughout the world, and Lancet is now confirming this with some shocking statistics. Rudd et al. (2020) present the most robust study yet on sepsis incidence and morta...

We'd like to wish everyone Happy Holidays and may 2020 be a year of happiness, health and productivity for you! 

Sepsis is unquestionably one of the most fatal conditions of our time, yet even patients who survive sepsis are still very much affected by the experience;

Hemotune focuses on controlling sepsis; the intense, and often life-threatening, response of the immune system to defend against pathogens and pathogen-derived proteins in the bloodstream. Although sepsis and septic shock are quite extreme manifestations of infection, every...

In this year's Wyss Annual Event start ups within the Wyss Zurich incubator, old and new, came together to present their work and raise awareness about their technology. The Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institut...

Sepsis arises from the urgency of the human body to attack infection - so much that the patient’s life is in danger. It is estimated that 30 million people are affected by sepsis annually, including 4 million newborns and children. Six million of these patients will die(1),...

It has been well documented that sepsis can happen to almost anyone and thus awareness is paramount in ensuring that appropriate and timely treatment is given. Although symptoms can vary, noticing a few signs early can prove life-saving.

Symptoms indicating the possibility of...

We recently got to introduce our magnetic blood purification system to the first Global Health Forum organized by Boao Forum for Asia in Qingdao, China. The focus of the forum was 'Health Beyond Health – In The Year of Sustainable Development 2030', bringing together healthc...

A recent article published in the Lancet highlights the rising threat to public health by antibiotic resistant bacteria. It is based on analysis of European health data from the year 2015. The study states that the burden of infection from antibiotic-resistant bacteria is si...

hemotune AG was selected for Phase I funding by the EU Horizon 2020 Small and Medium Enterprises (SME) Instrument.

The SME Instrument is part of the research and innovation program by the EU and supports groundbreaking innovative ideas for products, services or processes that...